JP2016503058A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016503058A5 JP2016503058A5 JP2015549612A JP2015549612A JP2016503058A5 JP 2016503058 A5 JP2016503058 A5 JP 2016503058A5 JP 2015549612 A JP2015549612 A JP 2015549612A JP 2015549612 A JP2015549612 A JP 2015549612A JP 2016503058 A5 JP2016503058 A5 JP 2016503058A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- formula
- compound
- thiosulfate
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261739609P | 2012-12-19 | 2012-12-19 | |
| US61/739,609 | 2012-12-19 | ||
| US201361758147P | 2013-01-29 | 2013-01-29 | |
| US61/758,147 | 2013-01-29 | ||
| PCT/US2013/076041 WO2014100135A1 (en) | 2012-12-19 | 2013-12-18 | Lfa-1 inhibitor formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016503058A JP2016503058A (ja) | 2016-02-01 |
| JP2016503058A5 true JP2016503058A5 (enExample) | 2016-07-28 |
| JP6373867B2 JP6373867B2 (ja) | 2018-08-15 |
Family
ID=50979140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015549612A Active JP6373867B2 (ja) | 2012-12-19 | 2013-12-18 | Ｌｆａ−１阻害剤製剤 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11058677B2 (enExample) |
| EP (2) | EP2934510B1 (enExample) |
| JP (1) | JP6373867B2 (enExample) |
| KR (1) | KR101891144B1 (enExample) |
| CN (1) | CN104955453B (enExample) |
| AU (1) | AU2013361579B2 (enExample) |
| BR (1) | BR112015014367B1 (enExample) |
| CA (1) | CA2894170C (enExample) |
| DK (1) | DK2934510T3 (enExample) |
| EA (2) | EA028008B1 (enExample) |
| ES (1) | ES2846724T3 (enExample) |
| HU (1) | HUE052299T2 (enExample) |
| IL (1) | IL239490B (enExample) |
| MX (2) | MX391620B (enExample) |
| NZ (1) | NZ708821A (enExample) |
| PL (1) | PL2934510T3 (enExample) |
| PT (1) | PT2934510T (enExample) |
| SI (1) | SI2934510T1 (enExample) |
| WO (1) | WO2014100135A1 (enExample) |
| ZA (2) | ZA201504404B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106995439B (zh) * | 2016-01-26 | 2019-09-20 | 镇江圣安医药有限公司 | 氘取代3-(甲磺酰基)-l-苯丙氨酸衍生物及其药物组合物、药物制剂和用途 |
| WO2019171260A1 (en) * | 2018-03-09 | 2019-09-12 | Mankind Pharma Ltd. | Pharmaceutical composition of lifitegrast |
| EP3955926A4 (en) * | 2019-04-18 | 2022-11-30 | Azura Ophthalmics Ltd. | Compounds and methods for the treatment of ocular disorders |
| EP3842032A1 (en) | 2019-12-24 | 2021-06-30 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | A pharmaceutical formulation |
| KR20230110516A (ko) * | 2020-10-21 | 2023-07-24 | 아주라 오프탈믹스 엘티디 | 눈 장애의 치료를 위한 화합물 및 방법 |
| CN116211796A (zh) * | 2022-12-30 | 2023-06-06 | 新领先(重庆)医药科技有限公司 | 一种立他司特滴眼液及其制备方法 |
| KR20240109779A (ko) * | 2023-01-05 | 2024-07-12 | 주식회사 종근당 | 리피테그라스트와 토코페롤을 함유하는 건성안 예방 또는 치료용 약제학적 조성물 |
| KR20250033790A (ko) | 2023-09-01 | 2025-03-10 | 주식회사 와이에스생명과학 | 리피테그라스트 함유 점안 조성물 |
| WO2025093739A1 (en) | 2023-11-02 | 2025-05-08 | Novaliq Gmbh | Semifluorinated alkane compositions comprising lifitegrast |
| WO2025104294A1 (en) * | 2023-11-17 | 2025-05-22 | Bausch + Lomb Ireland Limited | Semifluorinated alkane small molecule lfa-1 antagonist combination compositions for treatment of ocular disorders |
| CN117771174B (zh) * | 2023-12-29 | 2025-07-29 | 鲁南贝特制药有限公司 | 一种立他司特滴眼液及其制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2694719A (en) | 1949-02-12 | 1954-11-16 | Opplt Jan | Method of stabilizing ascorbic acid with alkali-thiosulfate-carbamide-complexes |
| JP3631490B2 (ja) * | 1992-05-13 | 2005-03-23 | ノバルティス ファーマ株式会社 | シクロスポリン含有眼科用組成物 |
| US5429819A (en) * | 1992-10-14 | 1995-07-04 | Matsushita Electric Industrial Co., Ltd. | Antiviral composition |
| IT1277707B1 (it) * | 1995-12-22 | 1997-11-11 | Chemedica Sa | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
| JP4138910B2 (ja) * | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤 |
| RU2149611C1 (ru) * | 1998-04-06 | 2000-05-27 | Московская медицинская академия им. И.М. Сеченова | Капли для лечения воспалительных заболеваний глаз (варианты) |
| DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
| US6258814B1 (en) * | 2000-10-13 | 2001-07-10 | Schering Corporation | Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep |
| US8877168B1 (en) * | 2002-07-31 | 2014-11-04 | Senju Pharmaceuticals Co., Ltd. | Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| EP1651195A4 (en) * | 2003-07-11 | 2007-10-03 | Myriad Genetics Inc | PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE |
| FI119361B (fi) | 2003-09-26 | 2008-10-31 | Raute Oyj | Menetelmä viilun sorvaamiseksi |
| US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
| JP5794721B2 (ja) * | 2005-05-17 | 2015-10-14 | サーコード バイオサイエンス インコーポレイテッド | 眼障害の治療のための組成物および方法 |
| EP1901708B1 (en) * | 2005-07-08 | 2013-09-11 | Senju Pharmaceutical Co., Ltd. | Percutaneously absorptive ophthalmic preparation comprising olopatadine |
| US7544893B2 (en) | 2007-07-25 | 2009-06-09 | Thomas & Betts International, Inc. | Extruded wire duct end cap |
| ITRM20080182A1 (it) * | 2008-04-07 | 2009-10-08 | Medivis S R L | Preparato oftalmico a base di dorzolamide e latanoprost per il trattamento topico del glaucoma. |
| JP2011521896A (ja) | 2008-04-15 | 2011-07-28 | サーコード コーポレイション | 免疫関連障害に対する局部治療に使用するための局所ｌｆａ−１アンタゴニスト |
| CN102065694A (zh) * | 2008-04-15 | 2011-05-18 | 萨可德公司 | 用于局部治疗免疫相关疾病的雾化的lfa-1拮抗剂 |
| US8080562B2 (en) * | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| WO2010033800A2 (en) * | 2008-09-19 | 2010-03-25 | Alacrity Biosciences, Inc. | Tetracycline stabilizing formulations |
| CN102176920B (zh) * | 2008-11-17 | 2013-09-18 | 莱拉制药用品私营有限责任公司 | 姜黄素及其用于治疗眼科疾病的方法 |
| EP2441453B1 (en) * | 2009-06-10 | 2014-11-26 | Mitotech SA | Pharmaceutical composition for use in medical and veterinary ophthalmology |
| KR20110001103A (ko) * | 2009-06-29 | 2011-01-06 | 에스케이케미칼주식회사 | 보관 안정성이 향상된 톨테로딘 함유 경피 투여 조성물 |
| BR112012012387A2 (pt) * | 2009-11-23 | 2019-09-24 | Allergan Inc | 7-[3,5-di-hidroxi-5-fenil-pent-1-enil)-ciclopentil]-n-etil-hept-5-enamida (bimatoprost) na forma cristalina ii, métodos para a preparação e métodos de utilização da mesma |
| US20120190653A1 (en) * | 2011-01-20 | 2012-07-26 | Dow Pharmaceutical Sciences, Inc. | Therapeutic eye drop comprising doxycycline and a stabilizer |
| US20130317058A1 (en) * | 2011-02-18 | 2013-11-28 | M/S. Appasamy Associates | Ophthalmic composition for enabling dilation of pupils |
| US20130005708A1 (en) * | 2011-06-29 | 2013-01-03 | Lalwani Dinusha N | Histamine antagonist treatment of inflammatory skin disorders |
| ES2978927T3 (es) * | 2012-03-29 | 2024-09-23 | Epion Therapeutics Inc | Soluciones de tratamiento ocular, dispositivos de administración y métodos de aumento de la administración |
| CN103230583A (zh) * | 2013-05-17 | 2013-08-07 | 江西省创欣药业集团有限公司 | 兽用治疗肠道疾病的烟酸诺氟沙星复方注射液及制备方法 |
-
2013
- 2013-12-18 MX MX2019012375A patent/MX391620B/es unknown
- 2013-12-18 MX MX2015007540A patent/MX368876B/es active IP Right Grant
- 2013-12-18 HU HUE13865757A patent/HUE052299T2/hu unknown
- 2013-12-18 AU AU2013361579A patent/AU2013361579B2/en active Active
- 2013-12-18 KR KR1020157019352A patent/KR101891144B1/ko active Active
- 2013-12-18 EA EA201591180A patent/EA028008B1/ru unknown
- 2013-12-18 EP EP13865757.2A patent/EP2934510B1/en active Active
- 2013-12-18 PT PT138657572T patent/PT2934510T/pt unknown
- 2013-12-18 WO PCT/US2013/076041 patent/WO2014100135A1/en not_active Ceased
- 2013-12-18 EP EP20204080.4A patent/EP3827823A1/en not_active Withdrawn
- 2013-12-18 NZ NZ708821A patent/NZ708821A/en unknown
- 2013-12-18 CN CN201380071760.5A patent/CN104955453B/zh active Active
- 2013-12-18 EA EA201791321A patent/EA201791321A1/ru unknown
- 2013-12-18 ES ES13865757T patent/ES2846724T3/es active Active
- 2013-12-18 CA CA2894170A patent/CA2894170C/en active Active
- 2013-12-18 BR BR112015014367-9A patent/BR112015014367B1/pt active IP Right Grant
- 2013-12-18 DK DK13865757.2T patent/DK2934510T3/da active
- 2013-12-18 SI SI201331833T patent/SI2934510T1/sl unknown
- 2013-12-18 US US14/650,955 patent/US11058677B2/en active Active
- 2013-12-18 JP JP2015549612A patent/JP6373867B2/ja active Active
- 2013-12-18 PL PL13865757T patent/PL2934510T3/pl unknown
-
2015
- 2015-06-18 ZA ZA2015/04404A patent/ZA201504404B/en unknown
- 2015-06-18 IL IL239490A patent/IL239490B/en active IP Right Grant
-
2016
- 2016-11-22 ZA ZA2016/08069A patent/ZA201608069B/en unknown
-
2021
- 2021-06-09 US US17/342,631 patent/US20220000859A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016503058A5 (enExample) | ||
| JP2019108388A5 (enExample) | ||
| JP2015527402A5 (enExample) | ||
| EA201492021A1 (ru) | Антительный состав | |
| BR112019025748A8 (pt) | Método para inibir o crescimento de cristal de roflumilast ou mudanças no tamanho de partícula em uma composição, composição farmacêutica e método de inibição de fosfodiesterase 4 em um paciente | |
| JP2017214429A5 (enExample) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2019529457A5 (enExample) | ||
| EA201790094A1 (ru) | Пестицидные композиции, содержащие изоксазолиновый активный ингредиент, и способы их применения | |
| RU2015137145A (ru) | Новые жидкие композиции с повышенной стабильностью | |
| MX2020010300A (es) | Sales monoacidas de 6-aminoisoquinolinas y usos de las mismas. | |
| JP2015007136A5 (enExample) | ||
| RU2016119746A (ru) | Стабильный состав инсулина глулизин | |
| JP2017507973A5 (enExample) | ||
| MY173867A (en) | Process to minimize polymorphism | |
| RU2013150861A (ru) | Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний | |
| JP2017514924A5 (enExample) | ||
| EA201891267A1 (ru) | Фармацевтическая композиция, содержащая действенный ингибитор urat1 | |
| RU2018112239A (ru) | Фармацевтическая композиция на основе трамадола для офтальмологического применения | |
| JP2018532806A5 (enExample) | ||
| WO2012071389A3 (en) | Stable cannabinoid compositions and methods for making and storing them | |
| RU2014140885A (ru) | Фармацевтическая композиция ибупрофена и трамадола для офтальмологического применения | |
| WO2018234871A3 (en) | COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE | |
| EA201490840A1 (ru) | Препарат с замедленным высвобождением | |
| EA201490363A1 (ru) | Новые составы на основе (триметоксифениламино)пиримидинилов |